ILADS and Lyme in the News
Targeting Multicopy Prophage Genes for the Increased Detection of Borrelia burgdorferi Sensu Lato (s.l.), the Causative Agents of Lyme Disease, in Blood
The successful treatment of Lyme disease (LD) is contingent on accurate diagnosis. However, current laboratory detection assays lack sensitivity in the early stages of the disease. Because delayed diagnosis of LD incurs high healthcare costs and great suffering, new highly sensitive tests are in need. To overcome these challenges, we developed an internally controlled quantitative…
Read MoreIntegrative & Functional Medicine Physicians from Amen Clinics To Speak at 2019 International Lyme & Associated Diseases Society Conference
Press Release: Amen Clinics, Inc. Source: BioSpace September 30, 2019 Read the press release
Read MoreReport on the Southern Tier Lyme Support Conference
Lyme Disease Conference, May 4, 2019 Report Southern Tier Lyme Support Inc. (hereafter, STLS) and Binghamton University (hereafter BU) co-hosted our fifth annual Lyme disease conference on May 4, 2019. Pre Conference Activities Last year, in Broome County, Lyme disease diagnoses jumped 36%. Over the previous five years, Lyme diagnoses increased 525%. Given these numbers,…
Read MoreLyme Disease Treatment Trends
Veterans Vista April 22. 2019 Read the full story
Read MoreEverything about Lyme disease is steeped in controversy. Now some doctors are too afraid to treat patients
The so-called controversy of Lyme disease is simple. On one hand, there is a sea of ignorance within the medical profession, and an ongoing denial by doctors that this tick-borne zoonosis exists. On the other hand, there is a concentration camp full of patients who can’t get prompt diagnosis and treatment. Unfortunately, the majority of…
Read MoreFind a tick on your dog, your child, or your shirt? Send it to Drexel
KYW-Newsradio (1060-AM) August 26, 2017 Read the full story
Read MoreLyme Disease on Rise Amid Diagnosis, Treatment Controversy
Lyme disease, tick-borne infections on rise as controversy over diagnosis, treatment persist
Guidelines adopted by insurers contributory to death of Lyme patients
Dr. Kenneth Liegner, ILADS board member, discusses the role of insurance companies in preventing the advancement Lyme treatment and care.
Read MoreTests for Lyme Miss Early Cases – But a New Approach Might Help
“‘I have to use clinical judgement quite often in early Lyme,” said Dr. Daniel Cameron, who leads a private practice specializing in Lyme in Mt. Kisco, N.Y., and has been treating Lyme for 30 years. “But there are doctors who are still waiting for that [positive] test, and if they can’t confirm it with a test, they’re reluctant to diagnose Lyme, and they don’t treat.’”
Read More